{"id":"W4362657072","doi":"10.1002/cam4.5799","title":"Symptomatic benefit of momelotinib in patients with myelofibrosis: Results from the <scp>SIMPLIFY</scp> phase <scp>III</scp> studies","year":2023,"lang":"en","type":"article","venue":"Cancer Medicine","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"ca_institutions":"St. Paul's Hospital; University of Toronto; University of British Columbia; University Health Network","funders":"Genentech; Italfarmaco; Cancer Research UK; Galecto; Sierra Oncology; Incyte; CTI Biopharma; Gilead Sciences; Medical Research Council; Celgene; Bristol-Myers Squibb; AstraZeneca; Amgen; Pfizer","keywords":"Repeated measures design; Medicine; Generalized estimating equation; Myelofibrosis; Clinical trial; Odds ratio; Odds; Quality of life (healthcare); Confidence interval; Longitudinal study; Physical therapy; Logistic regression; Internal medicine; Mathematics; Statistics","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0004482514,0.0004884729,0.001360291,0.0002738313,0.0001395809,0.00001213966,0.0002269212,0.0001193011,0.00002321501],"category_scores_gemma":[0.001987802,0.0002616447,0.0000959242,0.001288697,0.0004146477,0.00009894398,0.0001044763,0.000289436,0.0000341354],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002669384,"about_ca_system_score_gemma":0.0001776428,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007361917,"about_ca_topic_score_gemma":0.0004891976,"domain_scores_codex":[0.9966003,0.00008850575,0.001042234,0.0006805161,0.0009906788,0.0005978126],"domain_scores_gemma":[0.9943021,0.003729744,0.0005051207,0.0007174271,0.0004909139,0.0002546861],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0004286555,0.001269216,0.8806983,0.0004162648,0.002040726,0.0001005075,0.03647289,0.0001493803,0.0003832129,0.0001520392,0.06610368,0.01178512],"study_design_scores_gemma":[0.04367836,0.003193202,0.927215,0.005982522,0.0008628771,0.000002640454,0.01050812,0.0001504983,0.004677467,0.0001801771,0.00348233,0.00006679764],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.987592,0.006326127,0.00000322371,0.002772838,0.0004168006,0.001686661,0.0005316656,0.0001122289,0.0005584459],"genre_scores_gemma":[0.9923123,0.003837213,0.00006867237,0.001121238,0.0004622445,0.0007586179,0.0006085302,0.00006555626,0.0007656292],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.06262135,"threshold_uncertainty_score":0.9999835,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03805187361331621,"score_gpt":0.3312531560186777,"score_spread":0.2932012824053615,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}